YOLFTbeta
DarioHealth Corp

DarioHealth Corp

DRIO · NASDAQ · Healthcare / Health Information Services

1.26USD-0.39 (-23.64%)

Price History

Full chart

Market Stats

Previous Close1.65
Open1.62
Day Range1.26 – 1.65
52-Week Range5.84 – 17.74
Volume74.61K
Market Cap64.97M
P/E (TTM)0.00
Forward P/E10.59
EPS-14.87
Dividend Yield0.00%
Beta1.12
50-Day Avg7.17
200-Day Avg8.61

About

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Erez Raphael
  • Employees160
  • Headquarters322 W. 57th Street, New York, NY, United States, 10019, USA
  • Websitehttps://www.dariohealth.com

Leadership

  • Mr. Erez RaphaelCEO & Director · b. 1973
  • Ms. Chen Franco-YehudaCFO, Treasurer & Secretary · b. 1984
  • Dov OppenheimCo-Founder & Production Chief
  • Lara DodoChief Operations Officer
  • Zoe HarrisonVP of Accounting & Corporate Development
  • Kat ParrellaInvestor Relations Manager
  • Ms. Mona DeanChief Compliance Officer
  • Claudia LeviContent & Communications Manager
  • Mr. Rob HalpernSVP of Marketing
  • Dr. Omar Manejwala M.D.Chief Medical Officer

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-051.00K823.00K2.80M5.17M7.39M7.56M7.58M20.51M27.66M20.35M27.04M22.36M
Growth (%)---+1513.73%+240.58%+84.45%+43.02%+2.23%+0.22%+170.76%+34.82%-26.41%+32.86%-17.31%
Cost of Revenue-13.56M2.27M1.68M3.36M3.86M5.63M4.96M5.06M12.44M18.00M14.37M13.77M9.69M
Gross Profit--13.56M-2.22M-855.00K-561.00K1.31M1.76M2.60M2.51M8.07M9.65M5.98M13.27M12.66M
Gross Margin---4358.82%-103.89%-20.01%25.36%23.87%34.36%33.17%39.34%34.91%29.40%49.06%56.64%
Operating Expense-09.13M6.84M10.54M15.73M19.45M20.30M32.42M84.56M66.47M62.17M71.01M49.32M
Operating Income-3.97M-13.56M-11.36M-7.70M-11.10M-14.42M-17.69M-17.70M-29.90M-76.49M-56.81M-56.19M-57.74M-36.66M
Operating Margin---22270.59%-935.36%-396.04%-278.90%-239.22%-234.22%-394.71%-372.90%-205.42%-276.09%-213.55%-163.94%
EBITDA-2.34M-13.09M-10.32M-7.36M-10.45M-14.22M-17.48M-17.52M-29.71M-70.02M-55.60M-54.38M-37.08M-34.69M
EBITDA Margin---20235.29%-894.65%-372.64%-275.13%-236.42%-231.80%-392.20%-341.33%-201.03%-267.19%-137.12%-155.15%
Net Income-5.69M-13.93M-12.88M-7.14M-10.89M-15.74M-17.80M-17.74M-29.45M-76.76M-62.19M-59.43M-42.75M-41.71M
Net Income Margin---25249.02%-867.80%-388.41%-304.51%-240.78%-234.63%-388.66%-374.21%-224.88%-292.00%-158.09%-186.56%
R&D1.50M4.91M3.94M2.56M2.15M3.30M3.68M3.69M4.43M17.22M19.65M20.25M24.18M13.79M
R&D as % of Total Revenue--7731.37%311.66%76.85%63.77%49.72%48.84%58.51%83.94%71.05%99.49%89.42%61.68%
Interest Expense075.84K3.68M22.00K20.00K171.00K18.00K27.00K49.00K84.00K2.68M645.00K96.00K3.36M
Interest Expense % of Total Revenue--7215.69%2.67%0.71%3.31%0.24%0.36%0.65%0.41%9.70%3.17%0.36%15.02%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.32M4.12M3.08M5.08M3.87M6.96M14.09M24.57M35.41M100.77M119.19M96.39M118.88M110.08M
Total Liabilities3.38M4.20M5.62M4.30M10.41M3.02M5.16M5.67M7.26M15.22M39.19M38.24M46.87M42.15M
Total Equity-1.07M-86.38K-2.54M777.00K-6.54M3.94M8.93M18.89M28.15M85.55M80.00M58.14M72.02M67.92M
Cash1.23M2.26M1.45M2.67M1.09M3.72M11.00M20.59M28.59M36.00M49.36M36.80M27.76M26.25M
Total Debt--2.76M2.36M---772.00K532.00K287.00K28.05M29.54M30.19M31.75M
Net Debt-1.23M-2.26M1.30M-314.00K-1.09M-3.72M-11.00M-19.81M-28.06M-35.71M-21.31M-7.26M2.43M5.50M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.98M-7.60M-8.58M-6.28M-8.38M-10.62M-11.47M-15.72M-17.74M-50.41M-47.84M-30.38M-38.56M-25.94M
Investing Cash Flow-564.53K-1.64M-429.00K-113.00K-947.00K-219.00K6.00K-113.00K-1.62M-8.13M-573.00K-547.00K-8.93M-4.34M
Financing Cash Flow3.87M10.27M8.20M7.61M7.75M13.46M18.74M25.25M27.55M65.77M61.94M18.25M38.53M24.31M
Capital Expenditure534.63K1.40M563.00K110.00K808.00K195.00K71.00K98.00K118.00K261.00K573.00K584.00K138.00K142.00K
Free Cash Flow-3.52M-9.00M-9.14M-6.39M-9.19M-10.81M-11.54M-15.82M-17.85M-50.67M-48.42M-30.96M-38.70M-26.08M
Dividends Paid----------23.79M---
FCF to OCF117.92%118.43%106.56%101.75%109.64%101.84%100.62%100.62%100.67%100.52%101.20%101.92%100.36%100.55%
Dividend Paid to FCF-----------49.13%---

Earnings

Report DateAug 28, 2013Nov 12, 2013Mar 4, 2014May 15, 2014Aug 15, 2014Nov 14, 2014Mar 24, 2015May 14, 2015Aug 12, 2015Nov 13, 2015Feb 8, 2016May 11, 2016Aug 11, 2016Nov 10, 2016Mar 22, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Mar 19, 2018May 15, 2018Aug 9, 2018Nov 13, 2018Mar 25, 2019May 13, 2019Aug 13, 2019Oct 28, 2019Mar 17, 2020May 12, 2020Aug 12, 2020Nov 12, 2020Mar 9, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 22, 2022May 12, 2022Aug 15, 2022Nov 14, 2022Mar 9, 2023May 11, 2023Aug 10, 2023Nov 2, 2023Mar 28, 2024May 15, 2024Aug 8, 2024Nov 7, 2024Mar 26, 2025May 14, 2025Aug 12, 2025Nov 13, 2025Mar 19, 2026May 13, 2026Aug 11, 2026Nov 12, 2026
EPS Estimate--6480.01-306.00-5760.01-4680.00-5040.01------152.00-140.00-172.00-184.00-0.30-120.00-122.00-6.00-68.00-72.00-0.18-3.00-52.00-2.70-40.00-1.02-7.80-30.30-12.10-18.12-1.04-13.56-15.67-1.06-14.70-10.40-11.40-0.65-7.40-6.00-6.40-0.55-7.40-5.80-3.60-0.23-1.10-2.07-2.42-1.59-0.85-1.19-0.68
EPS Actual-10384.08-6120.0154.00-5040.01-5040.01-4752.00-77.26-27.87-25.69-17.59-11.49-132.00-196.00-124.00-384.000.45-172.00-120.00-25.20-80.00-128.00-3.40-2.20-60.00-2.60-24.00-7.72-31.40-13.60-14.20-21.20-0.92-17.95-14.98-1.09-17.05-14.15-8.25-0.51-4.90-8.34-6.48-0.500.93-4.06-3.67-0.04-2.38-4.09-2.22-0.77-0.95-0.85-
Surprise-5.56%117.65%12.50%-7.69%5.71%-----13.16%-40.00%27.91%-108.70%250.00%-43.33%1.64%-320.00%-17.65%-77.78%-1788.89%26.67%-15.38%3.70%40.00%-656.86%-302.56%55.12%-17.36%-17.00%11.54%-32.37%4.40%-2.83%-15.99%-36.06%27.63%21.54%33.78%-39.00%-1.25%9.09%112.57%30.00%-1.94%80.90%-116.36%-97.58%8.26%51.86%-11.76%28.57%-
Timing-Pre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap64.97M
Enterprise Value84.70M
Trailing P/E0.00
Forward P/E10.59
PEG Ratio0.00
Price / Sales3.09
Price / Book1.20
EPS-14.87
Book Value7.50
Revenue (TTM)21.00M
Gross Profit (TTM)12.93M
EBITDA-29.71M
Profit Margin-169.87%
Operating Margin-125.15%
Return on Equity-59.91%
Return on Assets-19.42%
Shares Outstanding9.80M
Shares Float7.61M
Beta1.12
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 13.60
  • Strong Buy
    3
  • Hold
    1

Ownership Breakdown

Institutions
9.10%
Insiders
15.93%
Retail / Other
74.97%

Top Institutional Holders

  • Nantahala Capital Management, LLC
    610.69K6.23%
  • Vanguard Capital Management, LLC
    65.91K0.67%
  • Geode Capital Management, LLC
    61.88K0.63%
  • Vanguard Fiduciary Trust Co
    30.07K0.31%
  • Citadel Advisors Llc
    24.29K0.25%
  • BlackRock Inc
    18.82K0.19%
  • UBS Group AG
    15.90K0.16%
  • Northern Trust Corp
    13.24K0.14%
  • Vanguard Global Advisers, LLC
    3.32K0.03%
  • Morgan Stanley - Brokerage Accounts
    1.00K0.01%
  • Royal Bank of Canada
    4480.00%
  • Tower Research Capital LLC
    4480.00%
  • Trust Co Of Toledo Na
    3520.00%

Top Fund Holders

  • Fidelity Extended Market Index
    32.25K0.33%
  • iShares Micro-Cap ETF
    19.94K0.20%
  • Fidelity Series Total Market Index
    8.75K0.09%
  • Fidelity Total Market Index
    7.63K0.08%
  • Vanguard U.S. Eq Idx £ Acc
    3.32K0.03%
  • 1290 VT Micro Cap K
    1.20K0.01%
  • DFA US Core Equity 1 I
    1.20K0.01%

Stock Splits

  • Aug 28, 20251:20